ENSG00000087299


Homo sapiens

Features
Gene ID: ENSG00000087299
  
Biological name :L2HGDH
  
Synonyms : L2HGDH / L-2-hydroxyglutarate dehydrogenase / Q9H9P8
  
Possible biological names infered from orthology :
  
Species: Homo sapiens
  
Chr. number: 14
Strand: -1
Band: q21.3
Gene start: 50237563
Gene end: 50312548
  
Corresponding Affymetrix probe sets: 220089_at (Human Genome U133 Plus 2.0 Array)   224459_at (Human Genome U133 Plus 2.0 Array)   224460_s_at (Human Genome U133 Plus 2.0 Array)   
  
Cross references: Ensembl peptide - ENSP00000451194
Ensembl peptide - ENSP00000450494
Ensembl peptide - ENSP00000452483
Ensembl peptide - ENSP00000261699
Ensembl peptide - ENSP00000267436
Ensembl peptide - ENSP00000405559
NCBI entrez gene - 79944     See in Manteia.
OMIM - 609584
RefSeq - XM_017021658
RefSeq - XM_005268075
RefSeq - XM_011537166
RefSeq - XM_011537167
RefSeq - XM_017021655
RefSeq - XM_017021656
RefSeq - XM_017021657
RefSeq - NM_024884
RefSeq Peptide - NP_079160
swissprot - G3V272
swissprot - G3V3E2
swissprot - G3V5S1
swissprot - C9JVN9
swissprot - Q9H9P8
Ensembl - ENSG00000087299
  
Related genetic diseases (OMIM): 236792 - L-2-hydroxyglutaric aciduria, 236792
See expression report in BioGPS
See gene description in Wikigenes
See gene description in GeneCards
See co-cited genes in PubMed


Ortholog prediction (from Ensembl)
Ortholog nameID Species
 l2hgdhENSDARG00000060500Danio rerio
 L2HGDHENSGALG00000012282Gallus gallus
 L2hgdhENSMUSG00000020988Mus musculus


Paralog prediction (from Ensembl)
Paralog nameIDSimilarity(%)
No match


Protein motifs (from Interpro)
Interpro ID Name
 IPR006076  FAD dependent oxidoreductase
 IPR036188  FAD/NAD(P)-binding domain superfamily


Gene Ontology (GO)
TypeGO IDTermEv.Code
 biological_processGO:0006103 2-oxoglutarate metabolic process TAS
 biological_processGO:0044267 cellular protein metabolic process IDA
 biological_processGO:0055114 oxidation-reduction process IEA
 cellular_componentGO:0005739 mitochondrion IEA
 cellular_componentGO:0005743 mitochondrial inner membrane TAS
 cellular_componentGO:0016021 integral component of membrane IDA
 cellular_componentGO:0031305 integral component of mitochondrial inner membrane NAS
 molecular_functionGO:0016491 oxidoreductase activity IEA
 molecular_functionGO:0047545 2-hydroxyglutarate dehydrogenase activity IDA


Pathways (from Reactome)
Pathway description
Interconversion of 2-oxoglutarate and 2-hydroxyglutarate


Phenotype (from MGI, Zfin or HPO)
IDPhenotypeDefinition Genetic BG
 HP:0000007 Autosomal recessive inheritance "A mode of inheritance that is observed for traits related to a gene encoded on one of the autosomes (i.e., the human chromosomes 1-22) in which a trait manifests in homozygotes. In the context of medical genetics, autosomal recessive disorders manifest in homozygotes (with two copies of the mutant allele) or compound heterozygotes (whereby each copy of a gene has a distinct mutant allele)." [HPO:curators]
Show

 HP:0000256 Macrocephaly "The presence of an abnormally large `skull` (FMA:46565)." [HPO:probinson]
Show

 HP:0000365 Hearing loss 
Show

 HP:0000486 Strabismus "Strabismus (also known as squint) is a condition in which the eyes are not properly aligned with each other." [HPO:curators]
Show

 HP:0000639 Nystagmus "Rhythmic, involuntary oscillations of one or both eyes related to abnormality in fixation, conjugate gaze, or vestibular mechanisms." [HPO:curators]
Show

 HP:0000648 Optic atrophy 
Show

 HP:0000708 Behavioural/Psychiatric Abnormality 
Show

 HP:0001250 Seizures "Seizures are an intermittent `abnormality of the central nervous system` (FMA:HP:0002011) due to a sudden, excessive, disorderly discharge of cerebral neurons and characterized clinically by some combination of disturbance of sensation, loss of consciousness, impairment of psychic function, or convulsive movements." [HPO:probinson]
Show

 HP:0001252 Muscular hypotonia "Muscular hypotonia is an abnormally low muscle tone (the amount of tension or resistance to movement in a muscle), often involving reduced muscle strength. Hypotonia is characterized by a diminished resistance to passive stretching." [HPO:curators]
Show

 HP:0001272 Cerebellar atrophy 
Show

 HP:0001285 Spastic tetraparesis "Spastic weakness affecting all four limbs." [HPO:curators]
Show

 HP:0002062 Abnormality of the pyramidal tracts "An abnormality of the pyramidal system of motor neurons, whose chief element, the corticospinal tract, is the only direct connection between the brain and the spinal cord. In addition to the corticospinal tract, the pyramidal system includes the corticobulbar, corticomesencephalic, and corticopontine tracts." [HPO:curators]
Show

 HP:0002071 Extrapyramidal signs 
Show

 HP:0002171 Gliosis 
Show

 HP:0002283 Diffuse brain atrophy 
Show

 HP:0002352 Leukoencephalopathy 
Show

 HP:0002357 Dysphasia 
Show

 HP:0002376 Developmental regression 
Show

 HP:0002383 Encephalitis 
Show

 HP:0003593 Early onset 
Show

 HP:0004375 Neoplasia of the nervous system 
Show

 HP:0006887 Mental retardation, progressive "Mental retardation is defined as a decreased intelligence quotient of varying degree. The term progressive mental retardation should be used if intelligence decreases/deteriorates over time." [HPO:curators]
Show

 HP:0007256 Mild pyramidal signs 
Show

 HP:0007258 Severe demyelination of the white matter 
Show

 HP:0007360 Aplasia/Hypoplasia of the cerebellum 
Show

 HP:0007371 Atrophy/Degeneration of the corpus callosum "The presence of atrophy (wasting) of the corpus callosum." [HPO:sdoelken]
Show

 HP:0010864 Mental retardation, severe "Moderate mental retardation is defined as an intelligence quotient (IQ) in the range of 20-34." [HPO:probinson]
Show

 HP:0040144 L-2-hydroxyglutaric aciduria 
Show

 HP:0040147 L-2-hydroxyglutaric acidemia 
Show

  


Interacting proteins (from Reactome)
Interactor ID Name Interaction type
No match






 

0 s.

 
External programs and data are copyrighted by and are the property of their respective authors.
The Manteia system, data and analyses are provided "as is" with no warranties, expressed or implied as to capabilities or accuracy. User assumes the entire risk as to the results and performance of the software, data and documentation


                   


© Olivier Tassy / Olivier Pourquie 2007-2024
contact: otassy@igbmc.fr